140 related articles for article (PubMed ID: 12725353)
41. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
[TBL] [Abstract][Full Text] [Related]
42. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization.
Zhan C; Miller MR
JAMA; 2003 Oct; 290(14):1868-74. PubMed ID: 14532315
[TBL] [Abstract][Full Text] [Related]
43. Measuring Epidemiologic Effects of Enterococcal Bacteremia and Outcomes From a Nationwide Inpatient Sample Database.
Cheriyath P; Prasad A; Patel P; Vankeshwaram V; Seeburun S; Ghodasara K; Pavuluri S
Cureus; 2022 Jul; 14(7):e27516. PubMed ID: 36060337
[TBL] [Abstract][Full Text] [Related]
44. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.
Bar K; Wisplinghoff H; Wenzel RP; Bearman GM; Edmond MB
BMC Infect Dis; 2006 Sep; 6():145. PubMed ID: 17002792
[TBL] [Abstract][Full Text] [Related]
45. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins.
de Kraker ME; Wolkewitz M; Davey PG; Koller W; Berger J; Nagler J; Icket C; Kalenic S; Horvatic J; Seifert H; Kaasch A; Paniara O; Argyropoulou A; Bompola M; Smyth E; Skally M; Raglio A; Dumpis U; Melbarde Kelmere A; Borg M; Xuereb D; Ghita MC; Noble M; Kolman J; Grabljevec S; Turner D; Lansbury L; Grundmann H
J Antimicrob Chemother; 2011 Feb; 66(2):398-407. PubMed ID: 21106563
[TBL] [Abstract][Full Text] [Related]
46. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients.
Renaud B; Brun-Buisson C;
Am J Respir Crit Care Med; 2001 Jun; 163(7):1584-90. PubMed ID: 11401878
[TBL] [Abstract][Full Text] [Related]
47. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
[TBL] [Abstract][Full Text] [Related]
48. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres.
Sheng WH; Wang JT; Lu DC; Chie WC; Chen YC; Chang SC
J Hosp Infect; 2005 Mar; 59(3):205-14. PubMed ID: 15694977
[TBL] [Abstract][Full Text] [Related]
49. Effect of nosocomial bloodstream infections on mortality, length of stay, and hospital costs in older adults.
Kaye KS; Marchaim D; Chen TY; Baures T; Anderson DJ; Choi Y; Sloane R; Schmader KE
J Am Geriatr Soc; 2014 Feb; 62(2):306-11. PubMed ID: 24438554
[TBL] [Abstract][Full Text] [Related]
50. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality.
Edmond MB; Ober JF; Dawson JD; Weinbaum DL; Wenzel RP
Clin Infect Dis; 1996 Dec; 23(6):1234-9. PubMed ID: 8953064
[TBL] [Abstract][Full Text] [Related]
51. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.
Garbutt JM; Ventrapragada M; Littenberg B; Mundy LM
Clin Infect Dis; 2000 Mar; 30(3):466-72. PubMed ID: 10722429
[TBL] [Abstract][Full Text] [Related]
52. Mortality due to vancomycin-resistant enterococcal bacteremia versus vancomycin-susceptible enterococcal bacteremia: an ecological analysis.
Hurley JC
Clin Infect Dis; 2005 Nov; 41(10):1541-2. PubMed ID: 16231272
[No Abstract] [Full Text] [Related]
53. Device-associated infection rates, device use, length of stay, and mortality in intensive care units of 4 Chinese hospitals: International Nosocomial Control Consortium findings.
Hu B; Tao L; Rosenthal VD; Liu K; Yun Y; Suo Y; Gao X; Li R; Su D; Wang H; Hao C; Pan W; Saunders CL
Am J Infect Control; 2013 Apr; 41(4):301-6. PubMed ID: 23040491
[TBL] [Abstract][Full Text] [Related]
54. [Nosocomial bacteremia in the adult patient. Study of associated costs].
Morano Amado LE; Del Campo Pérez V; López Miragaya I; Martínez Vázquez MJ; Vázquez Alvarez O; Pedreira Andrade JD
Rev Clin Esp; 2002 Sep; 202(9):476-84. PubMed ID: 12236937
[TBL] [Abstract][Full Text] [Related]
55. Community-acquired bacteremia at a teaching versus a nonteaching hospital: impact of acute severity of illness on 30-day mortality.
Mylotte JM; Kahler L; McCann C
Am J Infect Control; 2001 Feb; 29(1):13-9. PubMed ID: 11172313
[TBL] [Abstract][Full Text] [Related]
56. Effect of nosocomial infections due to antibiotic-resistant organisms on length of stay and mortality in the pediatric intensive care unit.
Foglia EE; Fraser VJ; Elward AM
Infect Control Hosp Epidemiol; 2007 Mar; 28(3):299-306. PubMed ID: 17326020
[TBL] [Abstract][Full Text] [Related]
57. Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay.
Allman RM; Goode PS; Burst N; Bartolucci AA; Thomas DR
Adv Wound Care; 1999; 12(1):22-30. PubMed ID: 10326353
[TBL] [Abstract][Full Text] [Related]
58. Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Shen WC; Chiang YC; Chen HY; Chen TH; Yu FL; Tang CH; Sue YM
Nephrology (Carlton); 2011 Nov; 16(8):697-703. PubMed ID: 21707841
[TBL] [Abstract][Full Text] [Related]
59. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome.
Gray JE; Richardson DK; McCormick MC; Goldmann DA
Pediatrics; 1995 Feb; 95(2):225-30. PubMed ID: 7838640
[TBL] [Abstract][Full Text] [Related]
60. Impact of nosocomial infections on medical costs, hospital stay, and outcome in hospitalized patients.
Sheng WH; Chie WC; Chen YC; Hung CC; Wang JT; Chang SC
J Formos Med Assoc; 2005 May; 104(5):318-26. PubMed ID: 15959598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
